These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 23859777)
1. Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors. Gunaherath GM; Marron MT; Wijeratne EM; Whitesell L; Gunatilaka AA Bioorg Med Chem; 2013 Sep; 21(17):5118-29. PubMed ID: 23859777 [TBL] [Abstract][Full Text] [Related]
2. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. Burlison JA; Avila C; Vielhauer G; Lubbers DJ; Holzbeierlein J; Blagg BS J Org Chem; 2008 Mar; 73(6):2130-7. PubMed ID: 18293999 [TBL] [Abstract][Full Text] [Related]
3. New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90. Le Bras G; Radanyi C; Peyrat JF; Brion JD; Alami M; Marsaud V; Stella B; Renoir JM J Med Chem; 2007 Nov; 50(24):6189-200. PubMed ID: 17979263 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors. Audisio D; Methy-Gonnot D; Radanyi C; Renoir JM; Denis S; Sauvage F; Vergnaud-Gauduchon J; Brion JD; Messaoudi S; Alami M Eur J Med Chem; 2014 Aug; 83():498-507. PubMed ID: 24992077 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors. Byrd KM; Subramanian C; Sanchez J; Motiwala HF; Liu W; Cohen MS; Holzbeierlein J; Blagg BS Chemistry; 2016 May; 22(20):6921-31. PubMed ID: 27037933 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90). Radanyi C; Le Bras G; Messaoudi S; Bouclier C; Peyrat JF; Brion JD; Marsaud V; Renoir JM; Alami M Bioorg Med Chem Lett; 2008 Apr; 18(7):2495-8. PubMed ID: 18304811 [TBL] [Abstract][Full Text] [Related]
7. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. Donnelly A; Blagg BS Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631 [TBL] [Abstract][Full Text] [Related]
8. Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90. Burlison JA; Neckers L; Smith AB; Maxwell A; Blagg BS J Am Chem Soc; 2006 Dec; 128(48):15529-36. PubMed ID: 17132020 [TBL] [Abstract][Full Text] [Related]
9. Hsp90 inhibitors identified from a library of novobiocin analogues. Yu XM; Shen G; Neckers L; Blake H; Holzbeierlein J; Cronk B; Blagg BS J Am Chem Soc; 2005 Sep; 127(37):12778-9. PubMed ID: 16159253 [TBL] [Abstract][Full Text] [Related]
10. Discovery and biological activity of 6BrCaQ as an inhibitor of the Hsp90 protein folding machinery. Audisio D; Messaoudi S; Cegielkowski L; Peyrat JF; Brion JD; Methy-Gonnot D; Radanyi C; Renoir JM; Alami M ChemMedChem; 2011 May; 6(5):804-15. PubMed ID: 21374821 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery. Burlison JA; Blagg BS Org Lett; 2006 Oct; 8(21):4855-8. PubMed ID: 17020320 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors. Kusuma BR; Khandelwal A; Gu W; Brown D; Liu W; Vielhauer G; Holzbeierlein J; Blagg BS Bioorg Med Chem; 2014 Feb; 22(4):1441-9. PubMed ID: 24461493 [TBL] [Abstract][Full Text] [Related]
13. Novobiocin Analogues That Inhibit the MAPK Pathway. Hall JA; Seedarala S; Zhao H; Garg G; Ghosh S; Blagg BS J Med Chem; 2016 Feb; 59(3):925-33. PubMed ID: 26745854 [TBL] [Abstract][Full Text] [Related]
14. Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C-terminal Inhibitors. Garg G; Forsberg LK; Zhao H; Blagg BSJ Chemistry; 2017 Nov; 23(65):16574-16585. PubMed ID: 28940589 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis. Chang DJ; An H; Kim KS; Kim HH; Jung J; Lee JM; Kim NJ; Han YT; Yun H; Lee S; Lee G; Lee S; Lee JS; Cha JH; Park JH; Park JW; Lee SC; Kim SG; Kim JH; Lee HY; Kim KW; Suh YG J Med Chem; 2012 Dec; 55(24):10863-84. PubMed ID: 23186287 [TBL] [Abstract][Full Text] [Related]
16. Novobiocin Analogs as Potential Anticancer Agents. Dlugosz A; Janecka A Mini Rev Med Chem; 2017; 17(9):728-733. PubMed ID: 28019639 [TBL] [Abstract][Full Text] [Related]
17. Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues. Peterson LB; Blagg BS Bioorg Med Chem Lett; 2010 Jul; 20(13):3957-60. PubMed ID: 20570149 [TBL] [Abstract][Full Text] [Related]
19. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins. Marcu MG; Schulte TW; Neckers L J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold. Jia JM; Liu F; Xu XL; Guo XK; Jiang F; Cherfaoui B; Sun HP; You QD Bioorg Med Chem Lett; 2014 Mar; 24(6):1557-61. PubMed ID: 24582477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]